Avalo Therapeutics Stock Probability of Future Stock Price Finishing Over 24.0
| AVTX Stock | USD 9.39 0.30 3.10% |
Avalo |
Avalo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Avalo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Avalo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Avalo Therapeutics had very high historical volatility over the last 90 days | |
| Avalo Therapeutics currently holds 537 K in liabilities with Debt to Equity (D/E) ratio of 5.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avalo Therapeutics has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Avalo Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.92 M. Net Loss for the year was (31.54 M) with loss before overhead, payroll, taxes, and interest of (7.94 M). | |
| Avalo Therapeutics currently holds about 11.25 M in cash with (30.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2. | |
| Avalo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of Avalo Therapeutics shares are held by institutions such as insurance companies |
Avalo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Avalo Stock often depends not only on the future outlook of the current and potential Avalo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avalo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 277.7 K | |
| Cash And Short Term Investments | 7.4 M |
Avalo Therapeutics Technical Analysis
Avalo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Avalo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Avalo Therapeutics. In general, you should focus on analyzing Avalo Stock price patterns and their correlations with different microeconomic environments and drivers.
Avalo Therapeutics Predictive Forecast Models
Avalo Therapeutics' time-series forecasting models is one of many Avalo Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Avalo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Avalo Therapeutics
Checking the ongoing alerts about Avalo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Avalo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Avalo Therapeutics had very high historical volatility over the last 90 days | |
| Avalo Therapeutics currently holds 537 K in liabilities with Debt to Equity (D/E) ratio of 5.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avalo Therapeutics has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Avalo Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.92 M. Net Loss for the year was (31.54 M) with loss before overhead, payroll, taxes, and interest of (7.94 M). | |
| Avalo Therapeutics currently holds about 11.25 M in cash with (30.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2. | |
| Avalo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Roughly 65.0% of Avalo Therapeutics shares are held by institutions such as insurance companies |
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.